Prevalence of sleep disorder/deprivation is found to be alarming among the Indian population. COVID-19 pandemic has resulted in significant increase in insomnia.  Insufficient sleep is considered to be a public health epidemic that is often unrecognized and under-reported. Burden of insomnia has been grossly underestimated. The effects of sleep disorders on the body are numerous and widely varied across multiple body systems. There are pharmacotherapies to aid in sleep but often are accompanied by huge adverse events. Recently there is lot of emphasize is to clinically validate the micronutrient and phytotherapy supplementation as a sustainable way of handling sleep disorders which are of mild to moderate severity and not secondary to any disease or disorder. In order to validate the hypothesis of usefulness of such interventions in primary insomnia, Sleepnite Tablet is a novel formula comprising herbal extracts and some assorted micronutrients, which are thought to be effective in management of insomnia and related symptoms.

The present research is an attempt of clinical validation of Sleepnite Tablet in patients suffering from insomnia. With the present research we can apply the knowledge from phytotherapy and nutrition along with the clinical trials to address important medical needs in insomnia patients to improve sleep. There is need to do primary translational work earliest & focus at some targeted aim and come up with a formulation for same to improve sleep quality and quantity, to improve daytime function, reduction of distress and changes associated with insomnia like fatigue, perceived stress, mood and cortisol levels. Which could be achieved through the present research. We can utilize these outcomes to develop a strategy for treating insomnia in more appropriate and assured way.